MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

Home・Akciju saraksts・Check Cap Ltd

C
Check Cap Ltd

Atvērts

1.52

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Galvenie mērījumi
By Trading Economics
Ienākumi	-9.4K
EBITDA	-1.3M

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	9.4M
Iepriekšējā atvēršanas cena	1.52
Iepriekšējā slēgšanas cena	1.52

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

0.73 / 0.96 Atbalsts un pretestība

Check Cap Ltd Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. janv. 23:54 UTC

Tirgus saruna

CBA Could Underperform Again in 2026 -- Market Talk

2026. g. 12. janv. 23:48 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 12. janv. 23:48 UTC

Tirgus saruna

Nikkei May Rise on Weaker Yen -- Market Talk

2026. g. 12. janv. 23:43 UTC

Tirgus saruna

Gold Edges Lower on Likely Technical Correction -- Market Talk

2026. g. 12. janv. 23:18 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

2026. g. 12. janv. 21:56 UTC

Tirgus saruna

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

2026. g. 12. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 12. janv. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 12. janv. 21:50 UTC

Tirgus saruna

Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 12. janv. 21:18 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 12. janv. 21:18 UTC

Tirgus saruna

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

2026. g. 12. janv. 20:54 UTC

Peļņas

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

2026. g. 12. janv. 20:48 UTC

Tirgus saruna

Oil Futures Settle Higher in Choppy Trade -- Market Talk

2026. g. 12. janv. 20:33 UTC

Tirgus saruna

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

2026. g. 12. janv. 20:18 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

2026. g. 12. janv. 20:18 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

2026. g. 12. janv. 19:39 UTC

Tirgus saruna

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

2026. g. 12. janv. 19:36 UTC

Tirgus saruna

Gold and Silver Set New Records on Fed Probe -- Market Talk

2026. g. 12. janv. 19:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 12. janv. 19:33 UTC

Tirgus saruna

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

2026. g. 12. janv. 19:24 UTC

Iegādes, apvienošanās, pārņemšana

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

2026. g. 12. janv. 19:22 UTC

Iegādes, apvienošanās, pārņemšana

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

2026. g. 12. janv. 18:21 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

2026. g. 12. janv. 18:20 UTC

Iegādes, apvienošanās, pārņemšana

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

2026. g. 12. janv. 18:19 UTC

Tirgus saruna

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

2026. g. 12. janv. 18:16 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

2026. g. 12. janv. 18:09 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 12. janv. 18:09 UTC

Tirgus saruna

Baidu's Outlook Bodes Well For Shares -- Market Talk

2026. g. 12. janv. 18:01 UTC

Iegādes, apvienošanās, pārņemšana

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

2026. g. 12. janv. 18:00 UTC

Tirgus saruna

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Salīdzinājums

Cenas izmaiņa

Check Cap Ltd Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Check Cap Ltd — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

0.73 / 0.96Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There is one bearish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Check Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.